TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors-Reference-Cited by-同舟云学术

TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors

Published:2016-03-18 Issue:17 Volume:7 Page:23715-23729
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Amin Amit Dipak¹,Li Lingxiao¹,Rajan Soumya S.²,Gokhale Vijay³⁴,Groysman Matthew J.⁵,Pongtornpipat Praechompoo³,Tapia Edgar O.⁶,Wang Mengdie⁶,Schatz Jonathan H.¹

Affiliation:

1. Department of Medicine, Division of Hematology-Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA

2. Sheila and David Fuente Graduate Program in Cancer Biology, University of Miami Miller School of Medicine, Miami, FL, USA

3. BIO5 Institute, University of Arizona, Tucson, AZ, USA

4. Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA

5. Undergraduate Biology Research Program, University of Arizona, Tucson, AZ, USA

6. Cancer Biology Graduate Interdisciplinary Program, University of Arizona, Tucson, AZ, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma;Nature Communications;2023-05-05

2. Primary resistance to first- and second-generation ALK inhibitors in a non-small cell lung cancer patient with coexisting ALK rearrangement and an ALK F1174L-cis-S1189C de novo mutation: A case report;Frontiers in Pharmacology;2022-11-23

3. Resistance to Targeted Agents Used to Treat Paediatric ALK-Positive ALCL;Cancers;2021-11-29

4. Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature;ESMO Open;2021-08

5. An insight into lung cancer: a comprehensive review exploring ALK TKI and mechanisms of resistance;Bosnian Journal of Basic Medical Sciences;2021-05-15